Metformin use and long-term risk of benign prostatic hyperplasia: a population-based cohort study

Danish cohort study (3953 metformin initiators and 5958 sulfonylurea users) found similar incidences of benign prostatic hyperplasia in men with diabetes (25.7 vs 27.4% incidence respectively).

BMJ Open